summary
Introduced
09/23/2020
09/23/2020
In Committee
09/23/2020
09/23/2020
Crossed Over
Passed
Dead
12/31/2020
12/31/2020
Introduced Session
116th Congress
Bill Summary
A bill to amend title XIX of the Social Security Act to clarify that drugs and biologicals used for medication-assisted treatment under Medicaid are subject to the requirements of the Medicaid Drug Rebate Program. This bill specifically includes in the Medicaid Drug Rebate Program covered outpatient drugs that are used in medication-assisted treatment for opioid-use disorders.
AI Summary
This bill, the Strengthening Medicaid Coverage of MAT Act, amends the Social Security Act to clarify that drugs and biologicals used for medication-assisted treatment (MAT) for opioid-use disorders are subject to the requirements of the Medicaid Drug Rebate Program. Specifically, the bill includes these MAT drugs and biologicals as "covered outpatient drugs" under the Medicaid Drug Rebate Program, ensuring they are subject to the same rebate requirements as other covered outpatient drugs. The amendments made by this bill take effect as if they were included in the enactment of the SUPPORT for Patients and Communities Act, passed in 2018.
Committee Categories
Budget and Finance
Sponsors (2)
Last Action
Read twice and referred to the Committee on Finance. (on 09/23/2020)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.congress.gov/bill/116th-congress/senate-bill/4674/all-info |
| BillText | https://www.congress.gov/116/bills/s4674/BILLS-116s4674is.pdf |
| Bill | https://www.congress.gov/116/bills/s4674/BILLS-116s4674is.pdf.pdf |
Loading...